Galectin-3在评估冠状动脉疾病后心肌梗死发生和预后中的价值

The Value of Galectin-3 in Evaluating the Occurrence and Prognosis of Myocardial Infarction after Coronary Artery Disease

目的:探讨Galectin-3在评估冠状动脉疾病后心肌梗死发生和患者预后的中的价值.方法:收集2016年1月-2017年4月收治的不稳定型心绞痛患者50例(观察组)及稳定型CAD患者50例(对照组),观察两组体内Galectin-3的表达水平;再将观察组依据Galectin-3水平分为三组,分析Galectin-3与病变血管支数的相关性,随访观察各组心肌梗死发生率及预后情况.结果:观察组吸烟患者占比、糖尿病患者占比、高密度脂蛋白、低密度脂蛋白及Galectin-3等指标均高于对照组,差异均有统计学意义(P<0.05).随着冠状动脉病变支数的增多,Galectin-3水平越高.≥3支血管病变患者Galectin-3水平均高于2支血管病变患者、1支血管病变患者,差异均有统计学意义(t=7.32、11.53,P<0.001);2支血管血管病变患者Galectin-3水平高于1支血管病变患者,差异有统计学意义(t=8.03,P<0.001).>8.6 ng/ml组心肌梗死发生率均高于<6.6 ng/ml组、6.6~8.6 ng/ml组,差异均有统计学意义(P<0.05).>8.6 ng/ml组死亡率均高于<6.6 ng/ml组、6.6~8.6 ng/ml组,差异均有统计学意义(P<0.05).结论:Galectin-3可作为一种评估冠状动脉疾病患者病情程度及预后的标记物,在临床上具有一定的应用价值.

Objective:To explore the value of Galectin-3 in evaluating the occurrence and prognosis of myocardial infarction after coronary artery disease.Method:A total of 50 patients with unstable angina pectoris(the observation group)and 50 patients with stable CAD(the control group)in our hospital from January 2016 to April 2017 were collected.Then the observation group was divided into three groups according to the level of Galectin-3.The correlation between Galectin-3 and the number of vessel branches was analyzed,and the incidence of myocardial infarction and prognosis of each group were followed up.Result:The proportion of smoking patients,diabetes patients,high density lipoprotein,low density lipoprotein and Galectin-3 in the observation group were all higher than those in the control group,the differences were statistically significant(P<0.05).As the number of coronary artery lesions increased,the higher the Galectin-3 level.The level of Galectin-3 of patients with≥3 vascular lesions1 vascular lesion was higher than those of patients with 2 vascular lesions and 1 vascular lesion,the differences were statistically significant(t=7.32,11.53,P<0.001),the Galectin-3 level of patients with 1 vascular lesion was higher than that of patients with 1 vascular lesion,the difference was statistically significant(t=8.03,P<0.001).The incidence of myocardial infarction in>8.6 ng/ml group was higher than those in<6.6 ng/ml group,6.6-8.6 ng/ml group,the differences were statistically significant(P<0.05).The mortality rate in>8.6 ng/ml group was higher than that in<6.6 ng/ml group,6.6-8.6 ng/ml group,the differences were statistically significant(P<0.05).Conclusion:Galectin-3 can be used as a marker to evaluate the severity and prognosis of patients with coronary artery disease,and it has certain clinical application value.